February 4, 2009 - Arizona Heart Institute will present the 22nd Annual Public Forum showcasing a live-telecast of the latest surgical treatments for heart and blood vessel disease on Tuesday, Feb. 10, 2009.
February 4, 2009 - The Medical Imaging & Technology Alliance (MITA) responds that the study by Jörg Hausleiter, M.D., in the Feb. 4 issue of the Journal of the American Medical Association (JAMA) correctly focuses on what providers need to know to ensure that computed tomography angiography (CTA) is utilized appropriately.
February 4, 2009 - In recent years, cardiac computed tomography angiography (CTA) has emerged as a useful diagnostic imaging modality for the assessment of coronary artery disease (CAD), and new research shows there are significantly lower doses of radiation associated with cardiac CTA than have been previously reported in several earlier studies.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 4, 2009 - According to a new market research report released this month by market research firm IMV Medical Information Division, the adoption of 64-slice CT equipment by cardiology practices throughout the U.S. has more than doubled over the past two years.
February 4, 2009 - On Thursday, Feb. 19 at 7:00 pm, The Halifax Health - Center for Cardiology, Daytona Beach, FL will present a live online panel discussion on an automated implantable cardiac defibrillator (ICD) surgical case.
February 3, 2009 - Bioheart Inc. has arranged with its Italian partner, Biomedica, for a complete grant-supported study of the Bioheart A&C Bio Science T-PLS Twin-Pulsatile Life Support System.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 3, 2009 – Medtronic has completed enrollment in PROTECT, the company’s global study comparing its Endeavor drug-eluting stent (DES) to Johnson & Johnson’s Cypher DES.
February 2, 2009 - Boston Scientific Corp. today said it began patient enrollment in the PLATINUM clinical trial, which is designed to evaluate the company’s PROMUS Element Everolimus-Eluting Coronary Stent.
February 2, 2009 - Cardiac Dimensions Inc. today said it received the CE Mark approval for its CARILLON Mitral Contour System from KEMA Quality B.V., a European Union Notified Body from the Netherlands.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 2, 2009 - CardiArc, Inc., along with Clinical Engineering Consultants Inc. (CEC) of Erlanger, KY, today said CEC will provide field service for the CardiArc HD-SPECT system. CEC also brings technical consultation with CardiArc on the field service manual. In addition CEC will sell the CardiArc system in the Ohio River Valley area.
February 3, 2009 - The FDA has granted Pathway Medical Technologies Inc., 510(k) clearance to market its newest peripheral atherectomy catheter, the Jetstream G2, for use in the treatment of peripheral artery disease (PAD) in the lower limbs.
February 3, 2009 - Cerenis Therapeutics SA, a privately held pharmaceutical company developing HDL-related compounds for the treatment of cardiovascular and metabolic diseases, has in-licensed intellectual property supporting an investigational new treatment of aortic valve stenosis (AVS) based on HDL therapy.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 3, 2009 – Barco closed the divestment operation of its Advanced Visualization (AVIS) activities to Toshiba Medical Systems Corp., Tokyo, Japan, in a move by Barco to focus on its medical display systems business.
February 2, 2009 - Diagnosoft Inc. has unveiled its newest software solution, the Diagnosoft SENC. Strain-encoding (SENC).
February 2, 2009 - A recent study published in Clinical Cardiology revealed that "emerging risk factors," including detailed cholesterol measurements such as HDL(2) and remnant lipoprotein particles, play a much greater role in determining heart disease risk than previously thought, and that traditional risk factors such as age, standard cholesterol levels and blood pressure do a poor job of predi